PetVivo Holdings Reports Increased Revenue Amid Ongoing Losses

Petvivo Holdings Inc ( (PETV) ) has released its Q2 earnings. Here is a breakdown of the information Petvivo Holdings Inc presented to its investors.

PetVivo Holdings, Inc., a company based in Edina, Minnesota, specializes in the development and commercialization of proprietary medical devices and biomaterials for treating animal afflictions, particularly focusing on dogs and horses. The company’s latest earnings report for the quarter ending September 30, 2025, highlights a significant increase in revenue compared to the previous year, driven primarily by sales to Vedco, Inc. However, the company continues to face substantial operating losses, with a net loss of $3.13 million for the quarter. Key financial metrics reveal that while revenues have increased to $303,284 for the quarter, operating expenses remain high at $2.29 million, leading to an operating loss of $2.07 million. The company’s strategic moves include signing exclusive licensing agreements with VetStem, Inc. and Digital Landia Holding Corp, aiming to expand its product offerings and market reach. Looking forward, PetVivo Holdings, Inc. remains focused on leveraging its innovative product pipeline and strategic partnerships to drive future growth, despite the current financial challenges.